| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 12.11.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 12.11.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 12.11.2024ISIN NameCA74734T1049 PYROGENESIS... ► Artikel lesen | |
| 04.11. | Nasdaq Stockholm AB: Delisting of Deversify Health AB (publ) from Nasdaq First North Growth Market | On November 4, 2024, Deversify Health AB (publ) was declared bankrupt by
Uppsala District Court.
According to item 8.2.7 of the Nasdaq First North Growth Market Rulebook, the
exchange may decide to... ► Artikel lesen | |
| 01.11. | XFRA 9BX: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILDEVERSIFY HEALTH... ► Artikel lesen | |
| 25.09. | Nasdaq Stockholm AB: New equity right for trading, Deversify Health AB (publ) | At the request of Deversify Health AB (publ), equity rights will be traded on
First North as from 26 September 2024.
TO3
Security name: DEVERSIFY HEALTH TO 3
-------------------------------------
Short... ► Artikel lesen | |
| 02.09. | Nasdaq Stockholm AB: The observation status for Deversify Health AB (publ) is removed | On January 23, 2024, the shares in Deversify Health AB (publ), formerly named
Euroafrica Digital Ventures AB (the "Company") were given observation status
with reference to a press release with information... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 30.10. | TC BioPharm macht Fortschritte bei Krebstherapie-Studien und sichert sich 8 Millionen US-Dollar | ||
| 30.10. | TC BioPharm advances cancer therapy trials, raises $8M | ||
| 25.10. | TC BioPharm Refutes Rumors Of Delisting From Nasdaq, Confirms Compliance With Nasdaq Requirements | ||
| 25.10. | TC BioPharm dementiert Gerüchte über Nasdaq-Delisting | ||
| 25.10. | TC BioPharm denies Nasdaq delisting rumors |
| Unternehmen / Aktien | Kurs | % |
|---|---|---|
| DEVERSIFY HEALTH AB | 0,000 | 0,00 % |
| TC BIOPHARM HOLDINGS PLC ADR | 0,650 | 0,00 % |
